Thermo Fisher Scientific (Massachusetts, USA) will acquire Life Technologies Corporation (California, USA) under the terms of a definitive agreement signed earlier this week.
Thermo Fisher Scientific (Massachusetts, USA) will acquire Life Technologies Corporation (California, USA) under the terms of a definitive agreement signed earlier this week.
The deal is estimated to be $76.00 a share at a total cost of $13.6 billion. The transaction was reportedly approved by both of the company’s board of directors, according to a press release.
Life Technologies is a global biotechnology company, and is recognized as a leading player in the development of sequencing technology. The acquisition will place Thermo Fisher as a key competitor in the development of advanced genetic testing, the potential key to personalized medicine.
“We are extremely excited about this transaction because it creates the ultimate partner for our customers and significant value for our shareholders,” said Marc N. Casper, President and CEO of Thermo Fisher Scientific.
Gregory T. Lucier, Chairman and CEO of Life Technologies, commented, “This transaction brings together two companies intent on accelerating innovation for our customers and achieving greater success in a highly competitive global industry.”
Lucier added: “This combination delivers immediate and significant cash value to our stockholders and represents a successful conclusion to the board’s strategic review to enhance stockholder value and develop an even stronger future for Life Technologies.”
For more information please visit:
www.lifetechnologies.com
or
www.thermoscientific.com
This story originally appeared in The Column. Click here to view that issue.
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.